Back
Adial Pharmaceuticals, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
31
ADIL
Adial Pharmaceuticals, Inc.
Last Price:
$0.24
Seasonality Move:
27.39%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atAdial Pharmaceuticals, Inc. Stock Forecast
-
Is Adial Pharmaceuticals, Inc. Stock Undervalued?The current Adial Pharmaceuticals, Inc. [ADIL] share price is $0.24. The Score for ADIL is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
ADIL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Adial Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Adial Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Adial Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
adial.com
52-Week Data
52-Week High:
1.30
52-Week Low:
0.22
Prediction Charts
Market Cap:
5.8M
Price in USD:
0.24
Volume:
258.3K
Beta:
1.00
Technical Analysis
SMA50:
0.30
SMA100:
0.33
SMA200:
0.44
52-Wk Change:
-76.27%
Stock Predictions
-
Is Adial Pharmaceuticals, Inc. stock public?Yes, Adial Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Adial Pharmaceuticals, Inc. stock quote today?The Adial Pharmaceuticals, Inc. stock price is 0.24 USD today.
-
How to buy Adial Pharmaceuticals, Inc. stock online?You can buy Adial Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 0.27 | 0.26 | 0.29 | 0.26 |
| Dec-18 | 0.26 | 0.26 | 0.28 | 0.26 |
| Dec-19 | 0.26 | 0.24 | 0.27 | 0.24 |
| Dec-22 | 0.24 | 0.24 | 0.26 | 0.24 |
| Dec-24 | 0.26 | 0.24 | 0.26 | 0.24 |
| Dec-26 | 0.25 | 0.23 | 0.25 | 0.23 |
| Dec-29 | 0.24 | 0.23 | 0.25 | 0.23 |
| Dec-30 | 0.23 | 0.23 | 0.23 | 0.23 |
| Dec-31 | 0.23 | 0.22 | 0.24 | 0.22 |
| Jan-5 | 0.24 | 0.26 | 0.27 | 0.24 |
| Jan-6 | 0.26 | 0.25 | 0.26 | 0.24 |
| Jan-7 | 0.25 | 0.24 | 0.26 | 0.24 |
| Jan-8 | 0.24 | 0.23 | 0.24 | 0.23 |
| Jan-9 | 0.24 | 0.24 | 0.25 | 0.23 |
Adial Pharmaceuticals, Inc. Earnings
Data Unavailable
Adial Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.03 per share.
* Adial Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.